MRNA vs VRTX: Which Stock is Better?
Side-by-side comparison of Moderna Inc and Vertex Pharmaceuticals Inc in 2026
MRNA
Moderna Inc
$53.57
VRTX
Vertex Pharmaceuticals Inc
$496.83
Key Metrics Comparison
| Metric | MRNA | VRTX | Winner |
|---|---|---|---|
| Market Cap | $20.93B | $126.19B | VRTX |
| P/E Ratio | N/A | 32.47 | VRTX |
| EPS (TTM) | $N/A | $15.30 | VRTX |
| Revenue Growth | -0.3% | 0.1% | VRTX |
| Gross Margin | -105.8% | 53.7% | VRTX |
Analyze MRNA
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MRNA or VRTX a better investment?
Comparing MRNA and VRTX: Moderna Inc has a market cap of $20.93B while Vertex Pharmaceuticals Inc has $126.19B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MRNA and VRTX?
MRNA (Moderna Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MRNA or VRTX?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MRNA or VRTX?
VRTX has higher revenue growth at 0.1% vs -0.3% for MRNA.
Which company is more profitable: MRNA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 53.7% compared to -105.8% for MRNA.
Which is the larger company: MRNA or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $126.19B compared to $20.93B for MRNA.
Should I buy MRNA or VRTX in 2026?
Both MRNA and VRTX have investment merit. MRNA trades at $53.57 while VRTX trades at $496.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MRNA and VRTX stock?
Key differences: Market Cap ($20.93B vs $126.19B), P/E Ratio (N/A vs 32.5x), Revenue Growth (-0.3% vs 0.1%), Gross Margin (-105.8% vs 53.7%).